These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization. Filicori M Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620 [No Abstract] [Full Text] [Related]
7. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation. Venturini PL; Remorgida V; Anserini P; De Cecco L Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583 [TBL] [Abstract][Full Text] [Related]
8. Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone. Mais V; Melis GB; Strigini F; Antinori D; de Ruggiero A; Fioretti P Fertil Steril; 1991 Jan; 55(1):80-5. PubMed ID: 1898894 [TBL] [Abstract][Full Text] [Related]
9. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
10. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results. Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792 [TBL] [Abstract][Full Text] [Related]
11. Pulsatile gonadotrophin releasing hormone stimulation after medium-term pituitary suppression in polycystic ovary syndrome. Scheele F; Hompes PG; van der Meer M; Schoute E; Schoemaker J Hum Reprod; 1993 Nov; 8 Suppl 2():197-9. PubMed ID: 8276960 [TBL] [Abstract][Full Text] [Related]
12. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease. Remorgida V; Venturini PL; Anserini P; Salerno E; de Cecco L Fertil Steril; 1991 Jan; 55(1):61-5. PubMed ID: 1898892 [TBL] [Abstract][Full Text] [Related]
13. Ovulation induction with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression by gonadotropin releasing hormone agonist in polycystic ovary disease. A cross-over study. Fulghesu AM; Lanzone A; Guida C; Nicoletti MC; Rossi P; Le Donne M; Caruso A; Mancuso S J Reprod Med; 1992 Oct; 37(10):834-40. PubMed ID: 1479563 [TBL] [Abstract][Full Text] [Related]
14. [Results of LHRH-A pretreatment in ovulation induction, using pulsatile administration of GnRH, in patients with polycystic ovaries]. D'Amato G; Vizziello G; Fanizza G Minerva Ginecol; 1992 May; 44(5):257-62. PubMed ID: 1608524 [TBL] [Abstract][Full Text] [Related]
15. Value of subcutaneous and intravenous pulsatile gonadotropin releasing hormone in polycystic ovary disease. Saffan DS; Seibel MM J Reprod Med; 1992 Jun; 37(6):545-51. PubMed ID: 1619610 [TBL] [Abstract][Full Text] [Related]
16. Ovulation induction with pulsatile luteinizing hormone-releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: endocrine results. Burger CW; Hompes PG; Korsen TJ; Schoemaker J Fertil Steril; 1989 Jan; 51(1):20-9. PubMed ID: 2491993 [TBL] [Abstract][Full Text] [Related]
17. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders. Saffan D; Seibel MM Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681 [TBL] [Abstract][Full Text] [Related]
18. A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome. Timmerman-van Kessel EC; Cikot RJ; Dargel-Donkers EJ; Zwertbroek W; van Dop PA; Schoot DC Fertil Steril; 2000 Jun; 73(6):1145-8. PubMed ID: 10856472 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of intravenous pulsatile gonadotropin-releasing hormone: Lutrepulse for injection. Santoro N Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1759-64. PubMed ID: 2122733 [TBL] [Abstract][Full Text] [Related]
20. Changing pituitary reactivity to follicle-stimulating hormone and luteinizing hormone-releasing hormone after induced ovulatory cycles and after anovulation in patients with polycystic ovarian disease. Blankstein J; Rabinovici J; Goldenberg M; Shaley J; Mehta A; Serr DM; Mashiach S J Clin Endocrinol Metab; 1987 Dec; 65(6):1164-7. PubMed ID: 3119650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]